Intestinal tuberculosis in a patient on infliximab treatment

Gastrointest Endosc. 2008 Jun;67(7):1178-9; discussion 1179. doi: 10.1016/j.gie.2007.12.048. Epub 2008 Mar 7.

Authors

Stephanos Karagiannis¹, Dimitrios Papaioannou, Spyros Goulas, Dimitrios Psilopoulos, Christos Mavrogiannis

Affiliation

¹ Department of Gastroenterology, Faculty of Nursing, Athens University, General Hospital of Athens Helena Venizelou, Athens, Greece.

PMID: 18329027
DOI: 10.1016/j.gie.2007.12.048

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects*
Antitubercular Agents / therapeutic use
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / immunology
Biopsy, Needle
Colonic Diseases / drug therapy
Colonic Diseases / etiology*
Colonic Diseases / pathology
Colonoscopy / methods
Female
Follow-Up Studies
Humans
Immunocompromised Host*
Immunohistochemistry
Infliximab
Intestinal Mucosa / pathology
Risk Assessment
Treatment Outcome
Tuberculosis, Gastrointestinal / drug therapy
Tuberculosis, Gastrointestinal / etiology*
Tuberculosis, Gastrointestinal / pathology

Substances

Antibodies, Monoclonal
Antitubercular Agents
Infliximab